These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7828627)

  • 1. The continuing important role of radionuclide generator systems for nuclear medicine.
    Knapp FF; Mirzadeh S
    Eur J Nucl Med; 1994 Oct; 21(10):1151-65. PubMed ID: 7828627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Technetium-99m production for use in nuclear medicine].
    Vucina J
    Med Pregl; 2000; 53(11-12):631-4. PubMed ID: 11320753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molybdenum-99 production from reactor irradiation of molybdenum targets: a viable strategy for enhanced availability of technetium-99m.
    Pillai MR; Knapp FF
    Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):385-99. PubMed ID: 23013668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future of low specific activity molybdenum-99/technetium-99m generator.
    Mushtaq A
    Curr Radiopharm; 2012 Oct; 5(4):325-8. PubMed ID: 22642420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods of increasing the performance of radionuclide generators used in nuclear medicine: daughter nuclide build-up optimisation, elution-purification-concentration integration, and effective control of radionuclidic purity.
    Le VS; Do ZP; Le MK; Le V; Le NN
    Molecules; 2014 Jun; 19(6):7714-56. PubMed ID: 24918542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m generators--the available options.
    Boyd RE
    Int J Appl Radiat Isot; 1982 Oct; 33(10):801-9. PubMed ID: 7152707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Efficacy of Sodium [99mTc] Pertechnetate from Low Specific Activity 99Mo/99mTc Autosolex Generator in Hospital Radiopharmacy Centre.
    Mitra A; Chattopadhyay S; Chandak A; Lad S; Barua L; De A; Kumar U; Chinagandham R; Upadhye T; Koundal K; Banerjee S; Rajan R
    Nucl Med Rev Cent East Eur; 2020; 23(1):1-14. PubMed ID: 32779168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained availability of 99mTc: possible paths forward.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2013 Feb; 54(2):313-23. PubMed ID: 23255729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Production and therapeutic use of rhenium-186, 188--the future of radionuclides].
    Vucina J; Han R
    Med Pregl; 2003; 56(7-8):362-5. PubMed ID: 14587255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic radionuclides: production and decay property considerations.
    Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
    J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhenium-188: availability from the (188)W/(188)Re generator and status of current applications.
    Pillai MR; Dash A; Knapp FF
    Curr Radiopharm; 2012 Jul; 5(3):228-43. PubMed ID: 22642385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhenium Radioisotopes for Medicine, a Focus on Production and Applications.
    Uccelli L; Martini P; Urso L; Ghirardi T; Marvelli L; Cittanti C; Carnevale A; Giganti M; Bartolomei M; Boschi A
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapy.
    Jeong JM; Knapp FF
    Semin Nucl Med; 2008 Mar; 38(2):S19-29. PubMed ID: 18243839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioarsenic from a portable (72)Se/(72)As generator: a current perspective.
    Ballard B; Nortier FM; Birnbaum ER; John KD; Phillips DR; Fassbender ME
    Curr Radiopharm; 2012 Jul; 5(3):264-70. PubMed ID: 22697482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internal radiation dose assessment of radiopharmaceuticals prepared with cyclotron-produced
    Meléndez-Alafort L; Ferro-Flores G; De Nardo L; Bello M; Paiusco M; Negri A; Zorz A; Uzunov N; Esposito J; Rosato A
    Med Phys; 2019 Mar; 46(3):1437-1446. PubMed ID: 30661241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of yttrium-90 from strontium-90: a nuclear medicine perspective.
    Chakravarty R; Dash A; Pillai MR
    Cancer Biother Radiopharm; 2012 Dec; 27(10):621-41. PubMed ID: 23009585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m -- new production and processing strategies to provide adequate levels for SPECT imaging.
    Osso JA; Catanoso MF; Barrio G; Brambilla TP; Teodoro R; Dias CR; Suzuki KN
    Curr Radiopharm; 2012 Jul; 5(3):178-86. PubMed ID: 22642387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there life after technetium: what is the potential for developing new broad-based radionuclides?
    Srivastava SC
    Semin Nucl Med; 1996 Apr; 26(2):119-31. PubMed ID: 8723506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM.
    Haynes NG; Lacy JL; Nayak N; Martin CS; Dai D; Mathias CJ; Green MA
    J Nucl Med; 2000 Feb; 41(2):309-14. PubMed ID: 10688116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactor-produced radioisotopes from ORNL for bone pain palliation.
    Knapp FF; Mirzadeh S; Beets AL; O'Doherty M; Blower PJ; Verdera ES; Gaudiano JS; Kropp J; Guhlke J; Palmedo H; Biersack HJ
    Appl Radiat Isot; 1998 Apr; 49(4):309-15. PubMed ID: 9519440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.